The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma.


Journal

Nutrition and cancer
ISSN: 1532-7914
Titre abrégé: Nutr Cancer
Pays: United States
ID NLM: 7905040

Informations de publication

Date de publication:
2023
Historique:
pubmed: 8 11 2022
medline: 25 2 2023
entrez: 7 11 2022
Statut: ppublish

Résumé

The prognostic value of the geriatric nutritional risk index (GNRI) is not clear in patients with diffuse large B-cell lymphoma (DLBCL). This study was designed to analyze the GNRI in DLBCL patients and to investigate its prognostic value in DLBCL. The archive records of DLBCL patients between 2008 and 2020 at the Akdeniz University Hospital were retrospectively analyzed. A total of 206 patients with DLBCL were recruited and classified into two GNRI-based groups based on nutrition status. The GNRI cut off value was determined by ROC analysis. In the univariate Cox regression analysis for overall survival (OS), age, lactate dehydrogenase, B symptoms, infiltration of bone marrow, and the GNRI were determined as prognostic factors for mortality. The OS of patients with a GNRI ≤104.238 was significantly lower than that of patients with a GNRI >104.238 (

Identifiants

pubmed: 36343361
doi: 10.1080/01635581.2022.2142248
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-598

Auteurs

Unal Atas (U)

Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Akdeniz University, Antalya, Turkey.

Hasan Sozel (H)

Faculty of Medicine, Department of Internal Medicine, Akdeniz University, Antalya, Turkey.

Utku Iltar (U)

Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Akdeniz University, Antalya, Turkey.

Orhan Kemal Yucel (OK)

Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Akdeniz University, Antalya, Turkey.

Ozan Salim (O)

Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Akdeniz University, Antalya, Turkey.

Levent Undar (L)

Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Akdeniz University, Antalya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH